Abstract
Objectives
This study was carried out to evaluate the diagnostic utility of FDG-PET/CT in patients with fever of unknown origin (FUO).
Methods
Medical records of 103 patients who underwent FDG-PET/CT and anatomic imaging as a part of FUO workup were analyzed. Final diagnosis of the cause of FUO was reached based on serologic assays, cultures, biopsy, surgery or 6 months of clinical follow-up.
Results
The definite cause of fever was established in 69/103 patients. Abnormal FDG uptake was found in 63/103 patients and contributed to the final diagnosis (TP) in 62 patients (98.48 %). Of the remaining 40 patients with negative PET/CT, the final definite cause of fever (FN) could be determined only in seven patients (17.5 %). PET/CT had a sensitivity, specificity, positive predictive value and negative predictive value of 90, 97, 98.4 and 82.5 % compared to 43.5, 67.6, 73.2 and 37.1 %, respectively, for anatomic imaging. FDG-PET/CT had a higher accuracy (92.2 vs. 51.5 %; p = 0.003) compared to anatomic imaging for suggesting a cause of FUO.
Conclusions
PET/CT showed high sensitivity and specificity in suggesting a definite diagnosis in the evaluation of FUO.
Similar content being viewed by others
References
Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40:1–30.
Durack DT, Street AC. Fever of unknown origin reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35–51.
Konecny P, Davidson RN. Pyrexia of unknown origin in the 1990s: time to redefine. Br J Hosp Med. 1996;56:21–4.
Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med. 1992;152:21–2.
Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970–1980. Medicine (Baltimore). 1982;61:269–92.
Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 1992; 152:51–5.
de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I. A perspective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392–400.
Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163:545–51.
Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, et al. A prospective multi- center study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86:26–38.
Gaeta GB, Fusco FM, Nardiello S. Fever of unknown origin: a systematic review of the literature for 1995–2004. Nucl Med Commun. 2006;27:205–11.
Chen K, Chen X. Positron emission tomography imaging of cancer biology: current status and future prospects. Semin Oncol. 2011;38:70–86.
Almuhaideb A, Papathanasiou N, Bomanji J. 18F-FDG PET/CT imaging in oncology. Ann Saudi Med. 2011;31:3–13.
Corstens FH, van der Meer JW. Nuclear medicine’s role in infection and inflammation. Lancet. 1999;354:765–70.
Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37.
Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff AS, de Geus-Oei LF, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mo Imaging. 2007;34:694–703.
Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191–6.
Balink H, Collins J, Bruyn G, Gemmel F. FDGPET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009;34:862–8.
Kei PL, Kok TY, Padhy AK, Ng DC, Goh AS. [18F] FDG PET/CT in patients with fever of unknown origin: a local experience. Nucl Med Commun. 2010;31:788–92.
Jasper N, Däbritz J, Frosch M, Loeffler M, Weckesser M, Foell D. Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging. 2010;37:136–45.
Pedersen TI, Roed C, Knudsen LS, Loft A, Skinhoj P, Nielsen SD. Fever of unknown origin: a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG- PET/CT. Scand J Infect Dis. 2012;44:18–23.
Rosenbaum J, Basu S, Beckerman S, Werner T, Torigian DA, Alavi A. Evaluation of diagnostic performance of (18)F-FDG-PET compared to CT in detecting potential causes of fever of unknown origin in an academic centre. Hell J Nucl Med. 2011;14:255–9.
Lopez Rodriguez M, Vazquez Munoz E, Gomez Cerezo J, Suárez García I, Ríos Blanco JJ, Atienza Saura M, et al. Cost effectiveness of computerized axial tomography in the diagnosis of traditional clinical picture of fever of unknown origin. Rev Clin Esp. 2005;205:19–23.
Quinn MJ, Sheedy PF 2nd, Stephens DH, Hattery RR. Computed tomography of the abdomen in evaluation of patients with fever of unknown origin. Radiology. 1980;136:407–11.
Bleeker-Rovers CP, van der Meer JW, Oyen WJ. Fever of unknown origin. Semin Nucl Med. 2009;39:81–7.
Klaeser B, Wiskirchen J, Wartenberg J, Weitzel T, Schmid RA, Mueller MD, et al. PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact. Eur J Nucl Med Mol Imaging. 2010;37:2027–36.
Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, et al. Fever of unknown origin: prospective comparison of FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000;27:1617–25.
Sheng JF, Sheng ZK, Shen XM, Bi S, Li JJ, Sheng GP, et al. Diagnostic value of fluorine- 18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin. Eur J Intern Med. 2011;22:112–6.
Kjaer A, Lebech AM, Eigtved A, Hojgaard A. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111 In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622–6.
Federici L, Blondet C, Imperiale A, Sibilia J, Pasquali JL, Pflumio F, et al. Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract. 2010;64:55–60.
Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49:1980–5.
WeilerSagie M, Bushelev O, Epelbaum R, Dann EJ, Haim N, Avivi I. (18)FFDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. 2010;51:25–30.
Wong TZ, van der Westhuizen GJ, Coleman RE. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am. 2002;12:615–26.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Manohar, K., Mittal, B.R., Jain, S. et al. F-18 FDG-PET/CT in evaluation of patients with fever of unknown origin. Jpn J Radiol 31, 320–327 (2013). https://doi.org/10.1007/s11604-013-0190-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-013-0190-z